With the Migraine Research Foundation reporting that migraine headaches affect 38 million people in the United States (more than diabetes and asthma put together), it's no surprise that Dr. Russell and Dr. Janda sees a lot of migraine patients in our Henderson, NV office. Although some people choose to relieve migraine pain with drugs, chiropractic care is a terrific, all-natural alternative that usually produces positive results.
For instance, one study published in the Journal of Manipulative and Physiological Therapeutics involved 127 patients ranging in age from 10 to 70-years-old who suffered with regular (at least monthly) migraines. Each subject received up to 16 chiropractic sessions. The patients noted that their headache frequency, duration, and disability two months before the study began, during the duration of the sessions (which was two months), and two months post-treatment.
What the authors discovered is that spinal manipulation therapy reduced the frequency, duration, and disability of the migraine headaches when compared with the control group who didn't receive chiropractic. Furthermore, this allowed them to take less medication for the pain, providing them an all-natural answer for a chronic condition.
Another study found that a combination of chiropractic and neck massage reduced migraine headaches almost 68%.
If you have migraine pain and are looking for help, call Dr. Russell and Dr. Janda today and request an appointment in our Henderson, NV chiropractic office. We'll do what we can to help you become pain-free!
Migraine Fact Sheet. Migraine Research Foundation. Retrieved from http://www.migraineresearchfoundation.org/fact-sheet.html on November 2, 2015
Noudeh Y et al. (2012). Reduction of current migraine headache pain following neck massage and spinal manipulation. International Journal of Therapeutic Massage & Bodywork;5(1):5-13
Tuchin P et al. (2000, February). A randomized controlled trial of chiropractic spinal manipulative therapy for migraine. Journal of Manipulative and Physiological Therapeutics;23(2):91-5